{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:42:28Z","timestamp":1786725748078,"version":"build-2736575974"},"reference-count":43,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose:<\/jats:title>\n                    <jats:p>It was aimed to compare corneal endothelial changes during the initial 12-month period in which patients started using atorvastatin after a diagnosis of acute coronary syndrome (ACS).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Forty-six participants (group 1) who underwent cardiac angioplasty and stenting for ACS and started using 80 mg atorvastatin in the early period were included in the study. In the study, a control group comprising 71 healthy adults (group 2) was included. These individuals did not use medication for any known systemic disease, had never taken statins, had no history of ocular surgery, and did not have any cornea-related eye diseases. Baseline and 12\n                      <jats:sup>th<\/jats:sup>\n                      month endothelial evaluations of group 1 and 2 participants were compared using specular microscopy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      There were 28 female and 18 male participants in group 1 and 48 female and 23 male participants in group 2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.455). The mean baseline corneal endothelial cell density (CECD) was not significantly higher in group 1 compared to group 2 (2471.4 \u00b1 200 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      vs 2428.2 \u00b1 539.8 cells\/mm\n                      <jats:sup>2<\/jats:sup>\n                      ,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.230). When the change between baseline and 12\n                      <jats:sup>th<\/jats:sup>\n                      month CECD was examined, the decrease in group 2 was significantly different from that in group 1 (-15,2 \u00b1 31,9 and -44,8 \u00b1 49,6,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0,002). Although the percentage of hexagonal cells decreased significantly in group 2 participants, no significant change was observed in group 1 (respectively;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.073). The endothelial cell coefficient of variation did not differ significantly in group 1 participants over a 1-year period (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.192), and a significant increase was observed in group 2 (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      &lt; 0.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>This study revealed that atorvastatin may have a positive effect on corneal endothelium cell density and morphology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/ijo.ijo_3201_23","type":"journal-article","created":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T08:09:33Z","timestamp":1722240573000},"page":"1142-1146","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of the effect of atorvastatin on corneal endothelial cells during the initial 12-month period after acute coronary syndrome"],"prefix":"10.4103","volume":"72","author":[{"given":"Murat","family":"Karapapak","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0130rem","family":"Demirtola","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merve","family":"Kelebek","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ece","family":"Ozal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhat","family":"Ermis","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadik","family":"Ozal","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ba\u015fak\u015fehir \u00c7am and Sakura City Hospital, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,29]]},"reference":[{"key":"R1-20260507","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0014-4835(76)90003-8","article-title":"Changes in the corneal endothelium as a function of age","volume":"22","author":"Laing","year":"1976","journal-title":"Exp Eye Res"},{"key":"R2-20260507","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/bjo.68.8.544","article-title":"Morphological change in the corneal endothelium due to ultraviolet radiation in welders","volume":"68","author":"Karai","year":"1984","journal-title":"Br J Ophthalmol"},{"key":"R3-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9394(82)90693-6","article-title":"Clinical \u0131nvestigations on the corneal endothelium","volume":"93","author":"Mishima","year":"1982","journal-title":"Am J Ophthalmol"},{"key":"R4-20260507","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.survophthal.2019.01.013","article-title":"Statins in ophthalmology","volume":"64","author":"Ooi","year":"2019","journal-title":"Surv Ophthalmol"},{"key":"R5-20260507","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2174\/1389450023347434","article-title":"HMG-Co A reductase \u0131nhibitors in the treatment of cardiovascular diseases: Stabilization of coronary artery plaque","volume":"3","author":"Morishita","year":"2002","journal-title":"Curr Drug Targets"},{"key":"R6-20260507","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/187152707781387260","article-title":"Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase \u0131nhibitors for the treatment of retinal and eye diseases","volume":"6","author":"Schmeer","year":"2007","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R7-20260507","first-page":"237.","article-title":"Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes. The MIRACL study","volume":"53","author":"Schwartz","year":"2001","journal-title":"Indian Heart J"},{"key":"R8-20260507","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1161\/01.CIR.95.5.1126","article-title":"Simvastatin, an HMG\u2013Coenzyme a reductase \u0131nhibitor, \u0131mproves endothelial function within 1 month","volume":"95","author":"O\u2019Driscoll","year":"1997","journal-title":"Circulation"},{"key":"R9-20260507","first-page":"280","article-title":"Is there a relationship between statin use and corneal specular microscopy and topography findings?","volume":"6","author":"Kurtul","year":"2021","journal-title":"Beyoglu Eye J"},{"key":"R10-20260507","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R11-20260507","first-page":"1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"R12-20260507","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.exer.2003.08.002","article-title":"Clinical responses of the corneal endothelium","volume":"78","author":"Bourne","year":"2004","journal-title":"Exp Eye Res"},{"key":"R13-20260507","first-page":"1","article-title":"Corneal endothelial cell density and morphology in healthy egyptian eyes","volume":"2019","author":"Abdellah","year":"2019","journal-title":"J Ophthalmol"},{"key":"R14-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12886-020-01385-1","article-title":"Corneal thickness and endothelial morphology in Normal Thai eyes","volume":"20","author":"Tananuvat","year":"2020","journal-title":"BMC Ophthalmol"},{"key":"R15-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2014\/852624","article-title":"Corneal endothelial cell density and morphology in healthy turkish eyes","volume":"2014","author":"Ar\u0131c\u0131","year":"2014","journal-title":"J Ophthalmol"},{"key":"R16-20260507","first-page":"333","article-title":"A comparative study of human corneal keratocyte and endothelial cell density during aging","volume":"16","author":"M\u00f8ller-Pedersen","year":"1997","journal-title":"Cornea"},{"key":"R17-20260507","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2147\/CIA.S51693","article-title":"Age-related changes in corneal thickness and endothelial characteristics","author":"Galgauskas","year":"2013","journal-title":"Clin Interv Aging"},{"key":"R18-20260507","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1177\/1759720X10384307","article-title":"The role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors (statins) in modern rheumatology","volume":"2","author":"Kotyla","year":"2010","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R19-20260507","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.amjcard.2006.09.018","article-title":"Molecular basis of differences among statins and a comparison with antioxidant vitamins","volume":"98","author":"Mason","year":"2006","journal-title":"Am J Cardiol"},{"key":"R20-20260507","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ophtha.2009.08.016","article-title":"Simvastatin and disease stabilization in normal tension glaucoma: A cohort study","volume":"117","author":"Leung","year":"2010","journal-title":"Ophthalmology"},{"key":"R21-20260507","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.ajo.2015.01.009","article-title":"Association between statin use and uveitis: Results from the pacific ocular \u0131nflammation study","volume":"159","author":"Borkar","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"R22-20260507","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1080\/02713683.2017.1355468","article-title":"Simvastatin as an adjunct to conventional therapy of non-infectious uveitis: A randomized, open-label pilot study","volume":"42","author":"Shirinsky","year":"2017","journal-title":"Curr Eye Res"},{"key":"R23-20260507","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1161\/01.CIR.97.12.1129","article-title":"Upregulation of endothelial nitric oxide synthase by HMG CoA reductase \u0131nhibitors","volume":"97","author":"Laufs","year":"1998","journal-title":"Circulation"},{"key":"R24-20260507","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00003226-199703000-00010","article-title":"Inhibition of corneal fibrosis by topical application of blocking antibodies to TGF beta in the rabbit","volume":"16","author":"Jester","year":"1997","journal-title":"Cornea"},{"key":"R25-20260507","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1089\/jir.1994.14.303","article-title":"Skin wound healing: Transforming growth factor beta antagonists decrease scarring and improve quality","volume":"14","author":"Ferguson","year":"1994","journal-title":"J Interferon Res"},{"key":"R26-20260507","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/wrr.12390","article-title":"A cell-based screening assay to identify pharmaceutical compounds that enhance the regenerative quality of corneal repair","volume":"24","author":"Gordon","year":"2016","journal-title":"Wound Repair Regen"},{"key":"R27-20260507","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.3892\/mmr.2017.6251","article-title":"Atorvastatin protects against contrast-induced nephropathy via anti-apoptosis by the upregulation of Hsp27 in vivo and in vitro","volume":"15","author":"He","year":"2017","journal-title":"Mol Med Rep"},{"key":"R28-20260507","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.biopha.2013.09.001","article-title":"Protective mechanisms of atorvastatin against doxorubicin-induced hepato-renal toxicity","volume":"68","author":"El-Moselhy","year":"2014","journal-title":"Biomed Pharmacother"},{"key":"R29-20260507","doi-asserted-by":"crossref","first-page":"6920","DOI":"10.1002\/jcp.30351","article-title":"Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of pyroptosis and neuroinflammation","volume":"236","author":"Chen","year":"2021","journal-title":"J Cell Physiol"},{"key":"R30-20260507","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1136\/bjo.87.9.1121","article-title":"The association between statin use and age related maculopathy","volume":"87","author":"McGwin","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"R31-20260507","doi-asserted-by":"crossref","first-page":"18280.","DOI":"10.1038\/srep18280","article-title":"The association between statin use and risk of age-related macular degeneration","volume":"5","author":"Ma","year":"2015","journal-title":"Sci Rep"},{"key":"R32-20260507","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/eye.2014.8","article-title":"Age-related macular degeneration and protective effect of HMG Co-A reductase inhibitors (statins): Results from the National Health and Nutrition Examination. Survey 2005\u20132008","volume":"28","author":"Barbosa","year":"2014","journal-title":"Eye"},{"key":"R33-20260507","doi-asserted-by":"crossref","first-page":"363.","DOI":"10.1001\/jamaophthalmol.2018.6399","article-title":"Association of statin therapy with prevention of vision-threatening diabetic retinopathy","volume":"137","author":"Kang","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"R34-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0168-8227(01)00341-2","article-title":"Simvastatin retards progression of retinopathy in diabetic patients with hypercholesterolemia","volume":"56","author":"Sen","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"R35-20260507","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/db10-0638","article-title":"Improvement of retinal vascular \u0131njury in diabetic rats by statins \u0131s associated with the \u0131nhibition of mitochondrial reactive oxygen species pathway mediated by peroxisome proliferator\u2013activated receptor \u03b3 coactivator 1\u03b1","volume":"59","author":"Zheng","year":"2010","journal-title":"Diabetes"},{"key":"R36-20260507","doi-asserted-by":"crossref","first-page":"1080.","DOI":"10.4103\/ijo.IJO_93_18","article-title":"The protective effect of simvastatin against ultraviolet B-induced corneal endothelial cell death","volume":"66","author":"Ho","year":"2018","journal-title":"Indian J Ophthalmol"},{"key":"R37-20260507","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/jop.2009.0025","article-title":"Lovastatin \u0131nhibits the thrombin-\u0131nduced loss of barrier \u0131ntegrity in bovine corneal endothelium","volume":"26","author":"Shivanna","year":"2010","journal-title":"J Ocul Pharmacol Ther"},{"key":"R38-20260507","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1002\/jcb.23173","article-title":"Impact of HMG-CoA reductase inhibition on oxidant-induced injury in human retinal pigment epithelium cells","volume":"112","author":"Qian","year":"2011","journal-title":"J Cell Biochem"},{"key":"R39-20260507","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1007\/s40264-013-0076-0","article-title":"Statin Use and Cataract Surgery: A nationwide retrospective cohort study in elderly ethnic chinese patients","volume":"36","author":"Lai","year":"2013","journal-title":"Drug Saf"},{"key":"R40-20260507","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1165\/rcmb.2003-0267OC","article-title":"Cytoskeletal activation and altered gene expression in endothelial barrier regulation by simvastatin","volume":"30","author":"Jacobson","year":"2004","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R41-20260507","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/01.CIR.102.23.2803","article-title":"Simvastatin \u0131mproves disturbed endothelial barrier function","volume":"102","author":"Amerongen GP van","year":"2000","journal-title":"Circulation"},{"key":"R42-20260507","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1161\/01.STR.28.11.2315","article-title":"Vascular effects of statins in stroke","volume":"28","author":"Delanty","year":"1997","journal-title":"Stroke"},{"key":"R43-20260507","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial \u0131nfarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3201_23","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T16:25:11Z","timestamp":1786724711000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/IJO.IJO_3201_23"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,29]]},"references-count":43,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_3201_23","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,29]]},"assertion":[{"value":"2023-12-08","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-17","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}